Genes Tech (8257): 13th Feb Scheme Vote
Back on the 14th November 2025, Genes Tech Group Holdings (8257 HK), a turnkey solutions provider, announced a rare, arm’s-length Offer, by way of a Scheme.
The Offeror, privately-held Tinicum, offered HK$0.245/share (not declared final), a 87% premium to undisturbed, and a four-plus-year high. Irrevocables comprising 74.79% of the register are now supportive. Super clean deal
The Scheme Doc is now out, with a Court Meeting on the 13th Feb 2026, and expected payment on the 10th March. The IFA (SBI Capital) says “fair & reasonable“.
Genes Tech is super illiquid. And a micro-cap. Look away now if this is not your bag
The Trade:
Very clean deal.
Trading at a gross/annualised spread of 1.7%/13.3%.
Keep reading with a 7-day free trial
Subscribe to Hong Kong/China M&A/Events to keep reading this post and get 7 days of free access to the full post archives.